Novel chiral bipyridine ligand as well as synthesis method and application thereof

Through the catalytic of the novel chiral bipyridine ligand with transition metal palladium or palladium copper, an asymmetric ring-opening/cross coupling reaction of cyclic diaryl iodide and secondary amine was achieved, and the reaction was difficult to succeed in the prior art. Problem, excellent yields and high optical purity products were obtained.

CN118930541AActive Publication Date: 2024-11-12UNIV OF SCI & TECH OF CHINA
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202410994996.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-12
Estimated Expiration
2044-07-24

AI Technical Summary

Technical Problem

In the prior art, chiral ligands containing the bipyridine structure of 5H cyclopentane [2,1-b:3,4-b'] have been almost not reported, and the asymmetry between cyclic diaryl iodide and secondary amines The open loop/cross coupling reaction was not successfully achieved.

Method used

A novel chiral bipyridine ligand was developed, using chiral 1,1'-binaphthalene-2,2'-dicarboxylic acid-oriented orthoarylation catalyzed by palladium acetate The reaction was catalyzed with the transition metal palladium or palladium-copper bimetallic, and the copper catalyzed asymmetric ring opening/cross coupling reaction combining methyl iodide and secondary amine, and the product was successfully obtained.

Benefits of technology

The product was obtained with excellent yield and high optical purity (ee value), solving the problem that the asymmetric ring-opening/cross coupling reaction of cyclic diaryl iodide and secondary amine is difficult to succeed.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930541A_ABST
    Figure CN118930541A_ABST
Patent Text Reader

Abstract

The invention discloses a novel chiral bipyridine ligand and a synthesis method and application thereof, the novel chiral bipyridine ligand is selected from compounds with the following structure: # imgabs0 #, the chiral ligand is successfully applied to copper-catalyzed asymmetric ring-opening / cross-coupling reaction of cyclic diaryl iodide and secondary amine, and a product is obtained with excellent yield and ee (enantiomeric excess) value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of organic synthesis, and specifically relates to a novel chiral bipyridine ligand and a synthesis method and application thereof. Background Art

[0002] Currently, bipyridine compounds are widely used. However, studies have found that nitrogen-containing bidentate chiral ligands with large open spaces, especially chiral ligands containing 5H cyclopentane[2,1-b:3,4-b']bipyridine structures, have rarely been reported. Summary of the invention

[0003] In view of the above research background, the present invention provides a novel chiral bipyridine ligand and its synthesis method and application. The chiral bipyridine ligand of the present invention is successfully applied in the copper-catalyzed asymmetric ring-opening / cross-coupling reaction of cyclic diaryl iodide and secondary amine to obtain the product with excellent yield and high ee value.

[0004] The novel chiral bipyridine ligand of the present invention is selected from the compounds with the following structures:

[0005]

[0006] The novel synthesis method of the chiral bipyridine ligand of the present invention uses chiral 1,1'-binaphthyl-2,2'-dicarboxylic acid 1 as a starting material and obtains the target ligand through two synthesis routes.

[0007] Route 1:

[0008] A 3,3'-functionalized derivative 2 was generated with a yield of 71% through a carboxylic acid-directed ortho-arylation reaction catalyzed by palladium acetate; compound 2 reacted with iodomethane in the presence of potassium carbonate to generate a diester, and the ester group was reduced to a hydroxyl group by LiALH4 in a tetrahydrofuran solvent, and then reacted with PBr3 to generate a dibromo compound 3; a 5H-cyclopentane [2,1-b:3,4-b'] bipyridine derivative was dissolved in tetrahydrofuran, and then a tetrahydrofuran solution of the dibromo compound 3 was added dropwise under ice bath conditions, the reaction was restored to room temperature with stirring, and after TLC detection of the reaction was complete, water was added to quench, and then ethyl acetate was added for extraction, the organic phases were combined, dried over sodium sulfate, and the organic solvent was removed by rotary evaporation to obtain a crude product, which was separated and purified to obtain the target ligand.

[0009] The reaction process of route 1 is as follows:

[0010]

[0011] Route 2:

[0012] Chiral 1,1'-binaphthyl-2,2'-dicarboxylic acid 1 was first esterified to obtain compound 5. Compound 5 was transmetallated at the ortho position of the ester group under the action of [Mg(TMP)2] reagent. After adding iodine, diiodide compound 6 was successfully obtained. DIBAL-H solution was added dropwise to the tetrahydrofuran solution of diiodide compound 6 at -78°C, and then stirred in an oil bath at 45°C to reduce the corresponding diol. The diol was successfully used to obtain benzyl dibromide 7 under the action of PBr3, and then dialkylated with 5H cyclopentane [2,1-b:3,4-b'] bipyridine to obtain diiodide compound 8 in excellent yield. Compound 8 was cross-coupled with arylborane or terminal alkyne compounds through a catalyst to obtain chiral bipyridine ligands with different structures in one step with good yield.

[0013] The catalyst is transition metal palladium, or transition metal palladium and copper bimetallic catalyst. Among them, transition metal palladium catalyzes the coupling reaction of compound 8 with arylborane; transition metal palladium and copper bimetallic catalysts the coupling reaction of compound 8 with terminal alkyne compounds.

[0014] The terminal alkyne compound is 1-ethynyl-4-methoxybenzene, which is coupled with compound 8 to obtain L3.

[0015] The aryl borane is selected from the compounds with the following structures, and is coupled with compound 8 to obtain L4-L9.

[0016]

[0017] The reaction process of route 2 is shown as follows:

[0018]

[0019] R2 is selected from the following groups:

[0020]

[0021] The application of the novel chiral bipyridine ligand of the present invention is to apply the chiral bipyridine ligand to the copper-catalyzed asymmetric ring-opening / cross-coupling reaction of cyclic diaryl iodide 9 and secondary amine 10 to obtain the product with excellent yield and ee value.

[0022] The cyclic diaryl iodide 9 is selected from one of the following structures:

[0023]

[0024] The secondary amine 10 is selected from one of the following structures:

[0025]

[0026] The asymmetric ring-opening reaction of cyclic diaryl iodide has not been successfully realized. The present invention provides a method for synthesizing a novel chiral bipyridine ligand. The chiral ligand L6 synthesized by the method realizes the asymmetric ring-opening / cross-coupling reaction of cyclic diaryl iodide and secondary amine under the co-catalysis of cuprous thiocyanate, and the product can be obtained with excellent yield and ee value. DETAILED DESCRIPTION

[0027] The technical solution of the present invention is further analyzed and explained below through specific embodiments.

[0028] Embodiment 1:

[0029]

[0030] Under nitrogen atmosphere, (S)-[1,1'-biphenyldicarboxylic acid]-2,2'-dicarboxylic acid (2.32 g, 6.8 mmol, 1.0 equiv), 4-iodo-1,1'-biphenyl (11.37 g, 40.6 mmol, 6.0 equiv), Pd(OAc)2 (152 mg, 10.0 mol%), Ag2CO3 (2.09 g, 7.5 mmol, 1.1 equiv) and K2CO3 (0.94 mg, 6.8 mmol, 1.0 equiv) were added to a Schlenk reaction tube. AcOH (4.0 mL) was then added. The mixture was stirred at 120°C for 24 hours, then cooled to room temperature and extracted with ethyl acetate. The organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=4 / 1, containing 1% AcOH) to give a colorless solid 2 (3.09 g, 71%).

[0031] 1 H NMR (600MHz, CDCl3) δ8.03 (s, 2H), 7.92 (d, J = 7.8Hz, 2H), 7.71-7.59 (m, 12H), 7.52 (t, J = 7.5Hz, 2H),7.46(t,J=7.5Hz,4H),7.38(t,J=7.5Hz,2H),7.29(t,J=7.8Hz,2H),7.11(d,J=9.0Hz,2H).

[0032] 13 C NMR (151MHz, CDCl3) δ171.9,140.6,140.5,138.8,135.8,133.7,132.9,132.0, 131.2,130.4,129.0,128.8,128.2,128.0,127.7,127.5,127.3,127.1,126.6.

[0033] HRMS(ESI)m / z:[M+Na] + Calcd for C 46 H 30 NaO4669.2036;Found669.2017.

[0034] Embodiment 2:

[0035]

[0036] Under nitrogen atmosphere, iodomethane (0.50mL, 8.0mmol, 8.0 equivalents) was added dropwise to a solution of compound 2 (646.7mg, 1.0mmol, 1.0 equivalents) and K2CO3 (1.11g, 8.0mmol, 8.0 equivalents) in THF (15.0mL) at 0°C. After complete addition, the cooling bath was removed and the reaction mixture was stirred at room temperature overnight. THF was removed under reduced pressure, the residue was dispersed in water and extracted with ethyl acetate. The combined organic layer was washed with an aqueous solution of sodium thiosulfate and brine and dried over Na2SO4. After filtration, the filtrate was concentrated and used in the next step without further purification. Under nitrogen atmosphere, the crude product was dissolved in THF (5.0mL) and LiAlH4 (160.0mg, 4.0mmol, 4.0 equivalents) was added at 0°C. After addition, the cooling bath was removed and the reaction mixture was stirred at 45°C for 4 hours. The reaction was quenched with NH4Cl solution, the mixture was extracted with ethyl acetate, washed with brine, dried with Na2SO4, filtered and concentrated. After filtration, the filtrate was concentrated and used for the next step without further purification. The crude product was dissolved in THF (5.0mL), cooled to 0 ° C, and PBr3 (0.37mL, 4.0mmol, 4.0 equivalents) was added dropwise. The reaction mixture was stirred at room temperature for 4 hours and extracted with ethyl acetate. The organic layer was washed with brine, dried with Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=20 / 1) to obtain a yellow solid 3 (0.61g, 82%).

[0037] 1 H NMR (600MHz, CDCl3) δ7.98 (s, 2H), 7.94 (d, J = 8.4z Hz,2H),7.74(t,J=7.2Hz,7H),7.72-7.69(m,5H),7.54(t,J=7.5Hz,2H),7.49(t,J=7.6Hz ,4H),7.39(t,J=7.4Hz,2H),7.35-7.29(m,2H),7.20(d,J=8.4Hz,2H),4.43-4.31(m,4H).

[0038] 13 C NMR (151MHz, CDCl3) δ140.8,140.7,140.5,139.6,136.6,133.3,132.5,132.0 ,130.6,130.1,129.0,128.1,127.5,127.5,127.4,127.3,127.0,126.7,32.3.

[0039] Embodiment 3:

[0040]

[0041] Under nitrogen atmosphere, 2-bromopropane (22.5mL, 0.24mol, 10.0 equivalents) was added dropwise to a mixture of THF-water (180.0mL, THF / H2O=2:1, v / v) of compound 1 (8.21g, 24.0mmol, 1.0 equivalents), Bu4NHSO4 (1.63g, 4.8mmol, 20.0%mol) and KF (13.94g, 0.24mmol, 10.0% equivalents). The reaction mixture was stirred overnight at 85°C and extracted with ethyl acetate. The organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=10 / 1) to give a colorless solid 5 (8.80g, 86%).

[0042] 1 H NMR (500MHz, CDCl3) δ8.18(d,J=9.0Hz,2H),8.01(d,J=8.5Hz,2H),7.93(d,J=8.5Hz,2H),7.50(ddd,J=8.1,6.8,1.1Hz,2H), 7.24(ddd,J=8.2,6.8,1.2Hz,2H),7.13(d,J=8.5Hz,2H),4.76(p,J=6.2Hz,2H),0.76(d,J=5.5Hz,6H),0.44(d,J=6.0Hz,6H).

[0043] 13 C NMR (126MHz, CDCl3) δ166.8,139.6,134.7,133.2,128.3,127.7,127.7,127.5,127.5,126.6,126.1,67.7,21.1,20.7.

[0044] HRMS(ESI)m / z:[M+Na] + Calcd for C 28 H 26O4Na 449.1724; Found449.1729.

[0045] Embodiment 4:

[0046]

[0047] Under nitrogen atmosphere, Mg(TMP)2 (50.0 mmol, 4.0 eq.) was added dropwise to a solution of 5 (5.78 g, 12.5 mmol, 1.0 eq.) in THF (40.0 mL) at 0°C, and the mixture was stirred at 45°C for 3 hours. The reaction system was then cooled to -78°C, I2 (22.80 g, 90 mmol, 7.2 eq.) dissolved in THF (40.0 mL) was added, and stirring was continued at 45°C for 3 hours before cooling to room temperature, the solvent was removed under reduced pressure, the residue was dispersed in water and extracted with dichloromethane. The combined organic layer was washed with an aqueous solution of sodium thiosulfate and sodium chloride and dried over Na2SO4. After filtration, the filtrate was concentrated under reduced pressure and purified by silica gel column chromatography (petroleum ether / ethyl acetate=10 / 1) to give 6 (5.51 g, 65%) as a yellow solid.

[0048] 1 H NMR (600MHz, CDCl3) δ8.52(s,2H),7.78(d,J=8.4Hz,2H),7.51(ddd,J=8.1,6.8,1.2Hz,2H),7.34(ddd,J=8.3 ,6.8,1.3Hz,2H),7.17(d,J=8.4Hz,2H),4.76(p,J=6.3Hz,2H),0.76(d,J=6.0Hz,6H),0.68(d,J=6.0Hz,6H).

[0049] 13 C NMR (151MHz, CDCl3) δ166.7,139.5,137.0,134.3,133.7,131.9,127.8,127.7,127.4,126.6,88.2,69.1,20.9,20.7

[0050] HRMS(ESI)m / z:[M+Na] + Calcd for C 28 H 24 I2O4Na 700.96576; Found700.9677.

[0051] Embodiment 5:

[0052]

[0053] Under nitrogen atmosphere, a solution of compound 6 (5.53 g, 8.2 mmol, 1.0 equivalent) in THF (20.0 mL) was cooled to -78 ° C, followed by dropwise addition of DIBAL-H (1.0 M toluene solution, 82.0 mL, 82 mmol, 10.0 equivalent). After complete dropwise addition, the reactant was slowly warmed to 45 ° C and stirred for 5 hours. The mixture was cooled to 0 ° C, diluted with a saturated Rochelle salt solution and stirred overnight. The remaining white suspension was filtered and washed with THF. Then extracted with dichloromethane and Et2O, the combined organic layers were dried with Na2SO4 and concentrated under vacuum, filtered. The filtrate was concentrated and used in the next step without further purification. The crude product was dissolved in a THF (80.0 mL) solution and cooled to 0 ° C, and PBr3 (3.1 mL, 32.8 mmol, 4.0 equivalent) was added dropwise. The reaction mixture was stirred at room temperature for 4 hours and then extracted with ethyl acetate. The organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / dichloromethane=2 / 1) to give a yellow solid 7 (4.62 g, 82%).

[0054] Embodiment 6:

[0055]

[0056] Under nitrogen atmosphere, a solution of compound 4a (336.4 mg, 2.0 mmol, 1.0 equivalent) in THF (20.0 ml) was cooled to 0 ° C, followed by the addition of KHMDS (1.0 M THF solution, 4.2 mL, 4.2 mmol, 2.1 equivalents). After the reaction mixture was stirred at room temperature for 0.5 hours, a solution of 7 (1.38 g, 2.0 mmol, 1.0 equivalent) in THF (40.0 mL) was added dropwise to the mixture at 0 ° C and stirred at room temperature for 2 hours. After the raw material was completely consumed, the mixture was quenched with saturated NH4Cl aqueous solution (30 mL) and extracted with dichloromethane (50 mL×3). The organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / dichloromethane=2 / 1) to give a yellow solid 8 (1.28 g, 92%).

[0057] 1H NMR (500MHz, CDCl3) δ8.81-8.71(m,2H),8.66(s,2H),7.89(d,J=8.0Hz,2H),7.51(ddd,J=8.0,6.7,1.1Hz,2H),7.29( ddd,J=8.3,6.8,1.3Hz,2H),7.25-7.18(m,4H),7.14(d,J=9.0Hz,2H),3.27(d,J=14.0Hz,2H),3.06(d,J=14.0Hz,2H).

[0058] 13 C NMR (126MHz, CDCl3) δ156.8,150.2,143.5,139.7,136.2,135.4,134.2,132.9,131.6,127.2,127.1,127.0,126.7,123.2,99.3,57.6,44.5.

[0059] HRMS(ESI)m / z:[M+H] + Calcd for C 33 H 21 Br2I2N2698.9789; Found 698.9796.

[0060] Embodiment 7:

[0061]

[0062] Under nitrogen atmosphere, compound 4a (168.2 mg, 1.0 mmol, 1.0 equiv) was dissolved in THF (15.0 ml) and cooled to 0 ° C. NaH (60% in mineral oil, 280.0 mg, 7.0 mmol, 7.0 equiv) was added. After the addition, the reaction mixture was stirred at room temperature for 0.5 hours. A solution of 3 (744.6 mg, 1.0 mmol, 1.0 equiv) in THF (15.0 mL) was added dropwise to the mixture at 0 ° C. and stirred at room temperature for 2 hours. After the raw material was completely consumed, the mixture was quenched with saturated NH4Cl aqueous solution (30 mL) and extracted with ethyl acetate (30 mL×3). The organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to obtain a colorless solid L1 (485.2 mg, 65%).

[0063] 1H NMR (600MHz, CDCl3) δ8.54(d,J=4.2Hz,1H),8.09(d,J=9.0Hz,2H),7.59(t,J=7.5Hz,1H),7.52(d,J=7.8Hz,2H),7.45(dd,J=15.9,8.2Hz,3H),7.41(t ,J=7.6Hz,2H),7.39-7.37(m,1H),7.37-7.30(m,3H),7.16-7.12(m,1H),7. 09(dd,J=7.6,4.9Hz,1H),3.27(dd,J=13.7,2.8Hz,1H),3.03-2.88(m,1H).

[0064] 13 C NMR (151MHz, CDCl3) δ156.5,149.6,144.3,140.3,140.0,139.8,139.2,136.3,132.62,132.60,132. 1,131.4,130.5,129.5,128.6,128.3,127.2,127.0,126.9,126.7,126.2,126.0,122.5,56.7,36.5.

[0065] HRMS(ESI)m / z:[M+H] + Calcd for C 57 H 39 N2751.3108; Found 751.3130.

[0066] Embodiment 8:

[0067]

[0068] Under nitrogen atmosphere, compound 4b (196.2 mg, 1.0 mmol, 1.0 equiv) was dissolved in THF (15.0 ml) and cooled to 0 ° C. NaH (60% in mineral oil, 280.0 mg, 7.0 mmol, 7.0 equiv) was added. After the addition, the reaction mixture was stirred at room temperature for 0.5 hours. A solution of 3 (744.6 mg, 1.0 mmol, 1.0 equiv) in THF (15.0 mL) was added dropwise to the mixture at 0 ° C. and stirred at room temperature for 2 hours. After the raw material was completely consumed, the mixture was quenched with saturated NH4Cl aqueous solution (30 mL) and extracted with ethyl acetate (30 mL×3). The organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to give a colorless solid L2 (377.0 mg, 48%).

[0069] 1 H NMR (600MHz, CDCl3) δ8.08-8.03(m,4H),7.57(ddd,J=8.0,6.6,1.2Hz,2H),7.51-7.48(m,4H),7.40(q,J=8.2Hz,10H),7.37-7.34(m ,2H),7.34-7.29(m,6H),6.98(d,J=7.8Hz,2H),6.92(d,J=7.8Hz,2H),3.20(d,J=13.8Hz,2H),2.87(d,J=13.8Hz,2H),2.57(s,6H). 13 C NMR (151MHz, CDCl3) δ158.8,156.4,142.1,140.7,140.2,140.0,139.5,136.4,133.2,132.8,132.3,1 31.6,130.7,129.6,128.8,128.5,127.4,127.3,127.2,126.9,126.3,126.1,122.1,56.4,36.8,24.5.

[0070] HRMS(ESI)m / z:[M+H] + Calcd for C 59 H 43 N2779.3421; Found 779.3413.

[0071] Embodiment 9:

[0072]

[0073] Under nitrogen atmosphere, 8 (41.9 mg, 0.060 mmol, 1.0 equiv), 1-ethynyl-4-methoxybenzene (46.7 μL, 0.36 mmol, 6.0 equiv), Pd2(dba)3 (5.5 mg, 10 mol%), dppf (6.7 mg, 20 mol%), CuI (2.3 mg, 20 mol%), Et3N (2.0 mL) and THF (1.0 mL) were added to the Schlenk tube in sequence. The resulting mixture was stirred at 45 ° C for 24 hours. After the reaction system was cooled to room temperature, it was quenched with brine and extracted with ethyl acetate (30 mL×3). The combined organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to obtain a colorless solid product L3 (30.4 mg, 43%).

[0074] 1H NMR (500MHz, CDCl3) δ8.67(dd,J=4.5,1.5Hz,2H),8.31(s,2H),7.99(d,J=8.0Hz,2H),7.52(dt,J=8.1,3.9Hz,2H),7.39(dd,J=7.8,1.5Hz,2H),7 .33-7.27(m,4H),7.15(dd,J=7.7,4.8Hz,2H),6.87-6.79(m,4H),6.76-6 .69(m,4H),3.76(s,6H),3.39(d,J=13.5Hz,2H),3.22(d,J=13.5Hz,2H).

[0075] 13 C NMR (126MHz, CDCl3) δ159.7,156.9,150.0,144.9,135.7,135.0,132.8,132.6,132.2,131 .4,128.1,127.2,126.8,126.2,122.9,122.0,114.5,113.9,93.9,87.0,57.7,55.2,38.6.

[0076] HRMS(ESI)m / z:[M+H] + Calcd for C 51 H 35 N2O2707.2693; Found 707.2695.

[0077] Embodiment 10:

[0078]

[0079] Under nitrogen atmosphere, 8 (41.9 mg, 0.060 mmol, 1.0 eq), (4-(phenylethynyl)phenyl)boronic acid (111.1 mg, 0.50 mmol, 8.3 eq), Pd(PPh3)4 (6.9 mg, 10.0 mol%), Na2CO3 (42.2 mg, 0.40 mmol, 6.7 eq), toluene (1.0 mL), MeOH (0.10 mL) and H2O (0.10 mL) were added to a Schlenk tube in sequence. The resulting mixture was stirred at 90°C for 12 hours. After the reaction system was cooled to room temperature, it was quenched with brine and extracted with ethyl acetate (30 mL×3). The combined organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to give the product L4 (35.9 mg, 75%) as a colorless solid.

[0080] 1 H NMR (600MHz, CDCl3) δ8.46(d,J=4.8Hz,2H),8.14-8.04(m,4H),7.59(t,J=7.5Hz,2H),7.50-7.43(m,8H),7.43-7.36(m,8H),7.3 5-7.30(m,2H),7.26-7.18(m,4H),7.13(d,J=7.8Hz,2H),7.00(t,J=6.3Hz,2H),3.25(d,J=13.8Hz,2H),2.87(d,J=13.8Hz,2H).

[0081] 13 C NMR (151MHz, CDCl3) δ156.5,149.6,144.3,140.9,140.70,140.66,140.3,136.2,132.7,132.6,132.1,1 31.4,129.5,129.1,128.9,128.6,128.3,127.3,127.1,127.0,126.2,126.1,125.9,122.4,56.8,36.6.

[0082] HRMS(ESI)m / z:[M+H] + Calcd for C 61 H 39 N2799.3108; Found 799.3105.

[0083] Embodiment 11:

[0084]

[0085] Under nitrogen atmosphere, 8 (41.9 mg, 0.060 mmol, 1.0 equiv), (3,5-dimethylphenyl)boronic acid (75.1 mg, 0.50 mmol, 8.3 equiv), Pd(PPh3)4 (6.9 mg, 10.0 mol%), Na2CO3 (42.2 mg, 0.40 mmol, 6.7 equiv), toluene (1.0 mL), MeOH (0.10 mL) and H2O (0.10 mL) were added to a Schlenk tube in sequence. The resulting mixture was stirred at 90°C for 12 h. After the reaction system was cooled to room temperature, it was quenched with brine and extracted with ethyl acetate (30 mL×3). The combined organic layers were washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to give the product L5 (32.2 mg, 82%) as a colorless solid.

[0086] 1 H NMR (600MHz, CDCl3) δ8.53(dd,J=4.2,1.8Hz,2H),8.03(d,J=8.4Hz,2H),7.98(s,2H),7.59-7.50(m,2H),7.39(d,J=9.0Hz,2H) ,7.37-7.30(m,2H),7.15-7.06(m,4H),6.83(s,4H),6.75(s,2H),3.15(d,J=13.8Hz,2H),2.77(d,J=13.8Hz,2H),2.16(s,12H).

[0087] 13 C NMR (151MHz, CDCl3) δ156.6,149.4,144.5,140.7,140.1,137.2,136.1,132.8,132.6,1 32.5,131.3,129.1,128.6,128.2,128.1,127.0,126.0,125.9,122.2,56.8,36.6,21.1.

[0088] HRMS(ESI)m / z:[M+H] + Calcd for C 49 H 39 N2655.3108; Found 655.3114.

[0089] Embodiment 12:

[0090]

[0091] Under nitrogen atmosphere, 8 (2.03 g, 2.9 mmol, 1.0 equiv), (9,9-dimethyl-9H-fluorene-2-yl)boric acid (4.14 g, 17.4 mmol, 6.0 equiv), Pd(PPh3)4 (335.0 mg, 10.0 mol%), Na2CO3 (1.54 g, 14.5 mmol, 5.0 equiv), toluene (60.0 mL), MeOH (6.0 mL) and H2O (6.0 mL) were added to a Schlenk tube in sequence. The resulting mixture was stirred at 90°C for 12 hours. After the reaction system was cooled to room temperature, it was quenched with brine and extracted with ethyl acetate (50 mL×3). The combined organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to obtain the product as a colorless solid. (2.27 g, 94%).

[0092] Embodiment 13:

[0093]

[0094] Under nitrogen atmosphere, 8 (69.8 mg, 0.10 mmol, 1.0 equiv), (9,9-dimethyl-9H-fluorene-3-yl)boric acid (142.8 mg, 0.60 mmol, 6.0 equiv), Pd(PPh3)4 (11.6 mg, 10.0 mol%), Na2CO3 (52.8 mg, 0.50 mmol, 5.0 equiv), toluene (2.0 mL), MeOH (0.20 mL) and H2O (0.20 mL) were added to a Schlenk tube in sequence. The resulting mixture was stirred at 90°C for 12 hours. After the reaction system was cooled to room temperature, it was quenched with brine and extracted with ethyl acetate (30 mL×3). The combined organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to give the product L7 (52.4 mg, 85%) as a colorless solid.

[0095] 1 H NMR(600MHz, CDCl3)δ8.41(s,2H),8.10-8.06(m,4H),7.63-7.50(m,6H),7.46-7.34(m,7H),7.30-7.27(m ,3H),7.24-7.12(m,6H),7.07-7.03(m,2H),3.25(d,J=13.8Hz,2H),2.94(d,J=13.8Hz,2H),1.38(s,12H).

[0096] 13 C NMR (151MHz, CDCl3) δ156.6,153.8,152.3,149.6,144.4,140.8,139.2,139.0,138.7,136.3,133.0,132.7,132.3,131.4, 129.7,129.2,128.3,127.3,127.1,126.8,126.2,126.0,122.6,122.4,122.1,121.8,119.7,56.9,46.6,36.6,27.1,26.9.

[0097] HRMS(ESI)m / z:[M+H] + Calcd for C 63 H 47 N2831.3734; Found 831.3727.

[0098] Embodiment 14:

[0099]

[0100] Under nitrogen atmosphere, 8 (69.8 mg, 0.10 mmol, 1.0 equiv), dibenzo[b,d]furan-3-ylboronic acid (127.2 mg, 0.60 mmol, 6.0 equiv), Pd(PPh3)4 (11.6 mg, 10.0 mol%), Na2CO3 (52.8 mg, 0.50 mmol, 5.0 equiv), toluene (2.0 mL), MeOH (0.20 mL) and H2O (0.20 mL) were added to a Schlenk tube in sequence. The resulting mixture was stirred at 90°C for 12 hours. After the reaction system was cooled to room temperature, it was quenched with brine and extracted with ethyl acetate (30 mL×3). The combined organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=2 / 1) to give the product L8 (68.5 mg, 88%) as a colorless solid.

[0101] 1 H NMR(600MHz, CDCl3)δ8.41(s,2H),8.10-8.06(m,4H),7.63-7.50(m,6H),7.46-7.34(m,7H),7.30-7.27(m ,3H),7.24-7.12(m,6H),7.07-7.03(m,2H),3.25(d,J=13.8Hz,2H),2.94(d,J=13.8Hz,2H),1.38(s,12H).

[0102] 13 C NMR (151MHz, CDCl3) δ156.6,153.8,152.3,149.6,144.4,140.8,139.2,139.0,138.7,136.3,133.0,132.7,132.3,131.4, 129.7,129.2,128.3,127.3,127.1,126.8,126.2,126.0,122.6,122.4,122.1,121.8,119.7,56.9,46.6,36.6,27.1,26.9.

[0103] HRMS(ESI)m / z:[M+H] + Calcd for C 63 H 47 N2831.3734; Found 831.3727.

[0104] Embodiment 15:

[0105]

[0106] Under nitrogen atmosphere, 8 (69.8 mg, 0.10 mmol, 1.0 equiv), 9-phenyl-9H-carbazole-2-yl)boric acid (127.2 mg, 0.60 mmol, 6.0 equiv), Pd(PPh3)4 (11.6 mg, 10.0 mol%), Na2CO3 (52.8 mg, 0.50 mmol, 5.0 equiv), toluene (2.0 mL), MeOH (0.20 mL) and H2O (0.20 mL) were added to a Schlenk tube in sequence. The resulting mixture was stirred at 90°C for 12 hours. After the reaction system was cooled to room temperature, it was quenched with brine and extracted with ethyl acetate (30 mL×3). The combined organic layer was washed with brine, dried over Na2SO4, and filtered. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate = 2 / 1) to obtain the product L9 (68.5 mg, 88%) as a colorless solid.

[0107] 1 H NMR (600MHz, CDCl3) δ8.30 (bs, 2H), 8.11-8.04 (m, 4H), 8.02 (d, J = 7.8Hz, 2H), 7. 89(d,J=7.8Hz,2H),7.65(s,4H),7.59-7.41(m,10H),7.39-7.34(m,4H),7.32(d ,J=8.4Hz,2H),7.30-7.26(m,2H),7.23(t,J=7.5Hz,2H),7.14-7.04(m,2H),7.0 1(d,J=7.2Hz,2H),6.62(bs,2H),3.15(d,J=13.8Hz,2H),2.76(d,J=13.8Hz,2H).

[0108] 13 C NMR (151MHz, CDCl3) δ156.3,149.4,144.3,141.22,141.15,140.4,138.3,137.5,136.1,133.0,132.5,132.1,131.3,129.8,129. 5,128.2,127.5,127.4,127.0,126.1,126.0,125.9,122.8,122.5,122.2,122.1,120.2,120.0,119.6,110.9,109.6,56.6,36.7.

[0109] HRMS(ESI)m / z:[M+H] +Calcd for C 69 H 45 N4929.3639; Found 929.3641.

[0110] Embodiment 16:

[0111]

[0112] Under nitrogen atmosphere, cyclic diaryliodonium salt 9a (68.4 mg, 0.15 mmol), CuSCN (1.2 mg, 10.0 mol%), L6 (12.5 mg, 15.0 mol%), CaO (11.2 mg. 0.2 mmol) and dichloromethane (1.0 mL) were added to the Schlenk tube in sequence. Then 1,2,3,4-tetrahydroquinoline (13.3 mg, 0.10 mmol) was added and stirred at room temperature for 24 h. The reaction mixture was filtered through diatomaceous earth. The filtrate was concentrated under reduced pressure, and the crude product was subjected to silica gel column chromatography (petroleum ether / ethyl acetate = 100:1) to obtain the corresponding product 11a (42.6 mg, 97%, 96% ee).

[0113] 1 H NMR(600MHz, CDCl3)δ7.75(d,J=7.8Hz,1H),7.30(d,J=8.1Hz,1H),7.28-7.25(m,1H),7 .17(t,J=8.1Hz,2H),6.93(dd,J=7.4,1.6Hz,1H),6.89(t,J=7.8Hz,1H),6.87-6.82(m,1 H),6.63(bs,1H),6.59(td,J=7.3,1.2Hz,1H),3.25(bs,1H),3.05(m,1H),2.74(dt,J=1 4.4, 6.5Hz, 1H), 2.59 (dt, J = 14.9, 6.4Hz, 1H), 2.04 (s, 6H), 1.70 (bs, 1H), 1.49 (bs, 1H).

[0114] 13 C NMR (151MHz, CDCl3) δ146.1,145.1,142.9,141.7,139.0,138.4,136.7,130.0,129.5,128 .6,128.5,127.3,126.1,125.8,123.2,117.0,115.3,102.9,50.2,27.8,22.0,21.6,20.3.

[0115] HRMS(ESI)m / z:[M+H] + Calcd for C23 H 23 NI 440.0870; Found 440.0873.

[0116] HPLCconditions: Chiralcel OD-H, isopropanol / hexane=0:100, flow:0.8mL / min, λ=320nm; t r =13.6min(major),17.3min(minor),96%ee.

[0117] Embodiment 17:

[0118]

[0119] Under nitrogen atmosphere, cyclic diaryliodonium salt 9a (68.4 mg, 0.15 mmol), CuSCN (1.2 mg, 10.0 mol%), L6 (12.5 mg, 15.0 mol%), CaO (11.2 mg. 0.2 mmol) and dichloromethane (1.0 mL) were added to the Schlenk tube in sequence. Benzomorpholine (13.5 mg, 0.10 mmol) was then added and stirred at room temperature for 24 h. The reaction mixture was filtered through diatomaceous earth. The filtrate was concentrated under reduced pressure, and the crude product was subjected to silica gel column chromatography (petroleum ether / ethyl acetate = 50:1) to obtain the corresponding product 11b (43.7 mg, 99%, 97% ee).

[0120] 1 H NMR (500MHz, CDCl3) δ7.78(d,J=7.5Hz,1H),7.31(dt,J=15.2,7.4Hz,2H),7.21(t,J=8.3Hz,2H),6.93(t,J=7.8Hz,1H),6.86-6. 71(m,2H),6.71-6.63(m,2H),4.11-3.94(m,1H),3.93-3.80(m,1H),3.38(bs,1H),3.18-3.04(m,1H),2.08(s,3H),2.06(s,3H).

[0121] 13 C NMR (126MHz, CDCl3) δ144.9,144.7,142.7,141.1,138.4,136.9,133.7,130.2,1 28.8,128.7,127.4,125.0,120.6,118.9,116.9,102.7,64.1,48.4,21.9,20.2.

[0122] HRMS(ESI)m / z:[M+H] + Calcd for C 22 H 21 INO 442.0663; Found 442.0667.

[0123] HPLCconditions: Chiralcel AD-H, isopropanol / hexane=0.3:99.7, flow:1.0mL / min, λ=320nm; t r =7.2min(minor),9.3min(major),97%ee.

[0124] Embodiment 18:

[0125]

[0126] Under nitrogen atmosphere, cyclic diaryliodonium salt 9a (68.4 mg, 0.15 mmol), CuSCN (1.2 mg, 10.0 mol%), L6 (12.5 mg, 15.0 mol%), CaO (11.2 mg. 0.2 mmol) and dichloromethane (1.0 mL) were added to the Schlenk tube in sequence. Then N-methylaniline (10.7 mg, 0.10 mmol) was added and stirred at room temperature for 24 h. The reaction mixture was filtered through diatomaceous earth. The filtrate was concentrated under reduced pressure, and the crude product was subjected to silica gel column chromatography (petroleum ether / ethyl acetate = 100:1) to obtain the corresponding product 11c (28.9 mg, 70%, 94% ee).

[0127] 1 H NMR (600MHz, CDCl3) δ7.74(d,J=7.8Hz,1H),7.31(t,J=7.8Hz,1H),7.19(ddd,J=7.5,5.0,1.1Hz,2H) ,7.14-7.07(m,3H),6.87(t,J=7.8Hz,1H),6.74-6.67(m,3H),2.88(s,3H),2.02(s,3H),1.98(s,3H).

[0128] 13 C NMR (151MHz, CDCl3) δ149.3,146.5,142.7,141.5,138.8,138.3,136.8,130.0 ,128.62,128.58,128.4,127.3,125.7,117.7,115.0,102.8,39.3,21.8,20.2.

[0129] HRMS(ESI)m / z:[M+H] + Calcd for C 21 H 21 IN 414.0714; Found 414.0728.

[0130] HPLC conditions: Chiralcel OD-H, isopropanol / hexane=0:100, flow:0.8mL / min, λ=320nm; t r =15.6min(major),22.6min(minor),94%ee.

[0131] Embodiment 19:

[0132]

[0133] Under nitrogen atmosphere, cyclic diaryliodonium salt 9b (79.2 mg, 0.15 mmol), CuSCN (1.2 mg, 10.0 mol%), L6 (12.5 mg, 15.0 mol%), CaO (11.2 mg. 0.2 mmol) and dichloromethane (1.0 mL) were added to the Schlenk tube in sequence. Benzomorpholine (13.5 mg, 0.10 mmol) was then added and stirred at room temperature for 24 h. The reaction mixture was filtered through diatomaceous earth. The filtrate was concentrated under reduced pressure, and the crude product was subjected to silica gel column chromatography (petroleum ether / ethyl acetate = 50:1) to obtain the corresponding product 11d (35.8 mg, 70%, 88% ee).

[0134] 1 H NMR (600MHz, CDCl3) δ8.04(d,J=8.4Hz,1H),8.00(d,J=8.4Hz,1H),7.94(dd,J=8.4,1.2Hz,1H),7.90-7.82(m,1H),7.70-7.60(m,2H),7. 48(ddd,J=8.0,6.7,1.1Hz,1H),7.44(bs,1H),7.32(t,J=7.3Hz,1H),7.21(bs,2H),6.83-6.58(m,3H),4.31-3.34(m,2H),3.05(bs,1H). 13C NMR(151MHz,CDCl3)δ144.8,140.4,136.1,135.6,134.0,133.5,133.0,131.7,129.9,129.4,128.2,127.1,127.0,126.9,126.6,126.1,125.80,125.77,120.7,119.7,116.8,64.3,48.3.

[0135] HRMS(ESI)m / z:[M+H] + Calcd for C 28 H 21 INO 514.0662;Found 514.0653.

[0136] HPLC conditions:Chiralcel AD-H,isopropanol / hexane=3:97,flow:1.0mL / min,λ=320nm;t r =6.7min(major),10.0min(minor),88%ee。

Claims

1. A novel chiral bipyridine ligand, characterized in that A compound selected from the following structures:

2. The method for synthesizing the novel chiral bipyridine ligand according to claim 1, characterized in that: Chiral 1,1'-binaphthyl-2,2'-dicarboxylic acid 1 is used as a starting material, and a carboxylic acid-directed ortho-arylation reaction catalyzed by palladium acetate is performed to generate a 3,3'-functionalized derivative 2 with a yield of 71%; compound 2 reacts with iodomethane under the action of potassium carbonate to generate a diester, and the ester group is reduced to a hydroxyl group by LiALH4 in a tetrahydrofuran solvent, and then reacts with PBr3 to generate a dibromo compound 3; a 5H-cyclopentane [2,1-b:3,4-b'] bipyridine derivative is dissolved in tetrahydrofuran, and then a tetrahydrofuran solution of the dibromo compound 3 is added dropwise under ice bath conditions, and the reaction is restored to room temperature with stirring. After TLC detection shows that the reaction is complete, water is added to quench, and then ethyl acetate is added for extraction, the organic phases are combined, dried over sodium sulfate, and the organic solvent is removed by rotary evaporation to obtain a crude product, which is separated and purified to obtain the target ligand L1 or L2; The synthetic route is as follows:

3. The method for synthesizing the novel chiral bipyridine ligand according to claim 1, characterized in that: Chiral 1,1'-binaphthyl-2,2'-dicarboxylic acid 1 was first esterified to obtain compound 5. Compound 5 was transmetallated at the ortho position of the ester group under the action of [Mg(TMP)2] reagent. After adding iodine, diiodide compound 6 was successfully obtained. At -78°C, DIBAL-H solution was added dropwise to the tetrahydrofuran solution of diiodide compound 6, and then stirred in an oil bath at 45°C to reduce the corresponding diol. The diol was successfully used to obtain benzyl dibromide 7 under the action of PBr3, and then dialkylated with 5H cyclopentane [2,1-b:3,4-b'] bipyridine to obtain diiodide compound 8 in excellent yield. Compound 8 was cross-coupled with arylborane or terminal alkyne compounds through a catalyst to obtain chiral bipyridine ligands L3-L9 with different structures. The reaction route is shown below:

4. The synthesis method according to claim 3, characterized in that: When compound 8 is subjected to a cross-coupling reaction with an arylborane or a terminal alkyne compound by means of a catalyst, the catalyst is a transition metal palladium, or a bimetallic catalyst of a transition metal palladium and copper.

5. The synthesis method according to claim 4, characterized in that: Transition metal palladium catalyzes the coupling reaction of compound 8 with arylborane; transition metal palladium and copper bimetallic catalyzes the coupling reaction of compound 8 with terminal alkyne compounds.

6. The synthesis method according to claim 5, characterized in that: The terminal alkyne compound is 1-ethynyl-4-methoxybenzene, which is coupled with compound 8 to obtain L3; The aryl borane is selected from the following compounds, and is coupled with compound 8 to obtain L4-L9:

7. The use of the novel chiral bipyridine ligand according to claim 1, characterized in that: The chiral bipyridine ligand is applied to the copper-catalyzed asymmetric ring-opening / cross-coupling reaction of cyclic diaryl iodide 9 and secondary amine 10 to obtain the product with excellent yield and ee value; The cyclic diaryl iodide 9 is selected from one of the following structures: The secondary amine 10 is selected from one of the following structures:

Citation Information

Patent Citations

  • Synthesis method of chiral ring-fused pyrazolone compound

    CN115286635A

  • Nickel-catalyzed pyridine C2-H bond asymmetric alkylation promoted by diamine-derived phosphine chiral phosphine oxide ligand

    CN115974927A

  • Preparation method of novel chiral bipyridine and application of novel chiral bipyridine in catalytic reaction

    CN118684669A

  • Synthesis of intermediates useful in preparing tricyclic compounds

    US5998620A

  • CU-and ni-catalyzed decarboxylative borylation reactions

    WO2018175173A1